Edgestream Partners’s Globus Medical GMED Stock Holding History

Edgestream Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Buy	+21,993	New	+$1.97M	0.06%	505
2025 Q4	–	Sell	-5,678	Closed	-$325K	–	1025
2025 Q3	$325K	Buy	+5,678	New	+$327K	0.01%	789
2024 Q4	–	Sell	-21,538	Closed	-$1.54M	–	942
2024 Q3	$1.54M	Buy	+21,538	New	+$1.52M	0.07%	471
2024 Q1	–	Sell	-27,945	Closed	-$1.49M	–	884
2023 Q4	$1.49M	Sell	27,945 -20,372	-42%	-$993K	0.11%	319
2023 Q3	$2.4M	Sell	48,317 -4,657	-9%	-$260K	0.19%	146
2023 Q2	$3.15M	Buy	+52,974	New	+$3.02M	0.29%	79

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgestream Partners's GMED Position: Q1 2026 in Review

Edgestream Partners opened a new position in Globus Medical (GMED) in Q1 2026: 21,993 shares worth $1.89M. The stake represents 0.06% of the portfolio and ranks #505 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in GMED as recently as Q3 2025.

Edgestream Partners first reported a position in GMED in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.15M in Q2 2023. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Edgestream Partners held 21,993 shares of Globus Medical worth $1.89M as of Q1 2026.
Globus Medical was a new Edgestream Partners position in Q1 2026.
Globus Medical made up 0.06% of Edgestream Partners's portfolio in Q1 2026, its #505 holding.
Edgestream Partners first reported a position in Globus Medical in Q2 2023 and has held it in 6 quarters since.
Edgestream Partners's Globus Medical position peaked at $3.15M in Q2 2023.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.